Home Kinnate Biopharma

Kinnate Biopharma

In operation
IPO
Developer of Novel Kinase Inhibitors
Basic
Enterprise Profile

Basic Information

Kinnate Biopharma is a precision oncology company dedicated to developing a range of therapies to treat patients with genomically defined vulnerabilities. Its focus is on the design and development of selective small molecules, with the mission of delivering the right drug to the right patient.
Kinnate Biopharma, Inc.
SanDiego,California,United States of America
less than 15 people
January 01, 2018
--

Enterprise Profile

Industrial Sector
Compound Discovery New Drug Development Manufacture of Biological Pharmaceutical Products Scientific Research and Experimental Development Services
Technology
Biotechnology
Concept
Disease Treatment Tumor
Application Scenarios
Innovative Drugs Biological Products